JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand · Delayed Price · Currency is THB 1.740
-0.010 (-0.57%)
Sep 3, 2026, 12:21 PM ICT
BKK:JSP Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 831 | 902 | 959 | 1,091 | 1,647 | 3,367 | |
Market Cap Growth | -4.89% | -5.94% | -12.17% | -33.73% | -51.08% | - |
Enterprise Value | 1,197 | 1,150 | 1,283 | 1,399 | 1,416 | 3,629 |
Last Close Price | 1.75 | 1.83 | 1.89 | 2.12 | 3.34 | 6.82 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.88 | 13.29 | 211.87 | - | - | 113.40 |
PS Ratio | 0.84 | 0.87 | 1.13 | 1.84 | 3.53 | 7.85 |
PB Ratio | 0.91 | 0.97 | 1.09 | 1.17 | 1.57 | 3.48 |
P/TBV Ratio | 0.97 | 1.03 | 1.17 | 1.31 | 1.58 | 3.50 |
P/FCF Ratio | - | - | 12.67 | - | - | 221.88 |
P/OCF Ratio | 7.05 | 6.89 | 7.26 | 27.05 | 586.21 | 65.10 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.21 | 1.10 | 1.52 | 2.35 | 3.03 | 8.46 |
EV/EBITDA Ratio | 8.10 | 7.17 | 8.71 | 41.02 | 87.13 | 57.70 |
EV/EBIT Ratio | 14.86 | 10.49 | 12.54 | - | - | 75.13 |
EV/FCF Ratio | - | - | 16.95 | - | - | 239.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.42 | 0.41 | 0.33 | 0.31 | 0.18 | 0.19 |
Debt / EBITDA Ratio | 2.62 | 2.14 | 1.77 | 6.28 | 7.61 | 2.63 |
Debt / FCF Ratio | - | - | 3.81 | - | - | 12.09 |
Net Debt / Equity Ratio | 0.38 | 0.36 | 0.29 | 0.29 | -0.11 | -0.48 |
Net Debt / EBITDA Ratio | 2.65 | 2.08 | 1.76 | 7.91 | -7.44 | -7.43 |
Net Debt / FCF Ratio | -2.15 | -2.25 | 3.42 | -2.04 | 0.42 | -30.80 |
Asset Turnover | 0.71 | 0.75 | 0.64 | 0.44 | 0.36 | 0.49 |
Inventory Turnover | 4.62 | 5.40 | 4.63 | 4.29 | 3.00 | 2.97 |
Quick Ratio | 0.80 | 0.96 | 0.81 | 0.74 | 2.94 | 6.23 |
Current Ratio | 1.27 | 1.39 | 1.37 | 1.26 | 3.65 | 7.19 |
Return on Equity (ROE) | 2.71% | 4.99% | -3.66% | -0.37% | -1.73% | 5.11% |
Return on Assets (ROA) | 3.63% | 4.91% | 4.80% | -0.02% | -0.05% | 3.46% |
Return on Invested Capital (ROIC) | 2.20% | 4.13% | 8.74% | 0.03% | -0.15% | 8.48% |
Return on Capital Employed (ROCE) | 6.80% | 8.90% | 9.30% | 0.00% | -0.10% | 4.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.17% | 7.53% | 0.47% | -0.16% | -1.06% | 0.88% |
FCF Yield | -19.29% | -16.45% | 7.90% | -12.14% | -17.36% | 0.45% |
Dividend Yield | 2.45% | 5.46% | 1.67% | - | - | 0.19% |
Payout Ratio | 108.29% | 36.77% | 331.39% | - | - | 94.30% |
Buyback Yield / Dilution | -12.81% | -0.00% | -1.16% | 2.35% | -33.27% | -7.51% |
Total Shareholder Return | -10.36% | 5.46% | 0.51% | 2.35% | -33.27% | -7.32% |